TN2014000127A1 - EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME - Google Patents

EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME

Info

Publication number
TN2014000127A1
TN2014000127A1 TNP2014000127A TN2014000127A TN2014000127A1 TN 2014000127 A1 TN2014000127 A1 TN 2014000127A1 TN P2014000127 A TNP2014000127 A TN P2014000127A TN 2014000127 A TN2014000127 A TN 2014000127A TN 2014000127 A1 TN2014000127 A1 TN 2014000127A1
Authority
TN
Tunisia
Prior art keywords
rapid
producing
effective
pharmaceutical composition
same
Prior art date
Application number
TNP2014000127A
Other languages
French (fr)
Inventor
Said Nabil
Original Assignee
Said Nabil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Said Nabil filed Critical Said Nabil
Priority to TNP2014000127A priority Critical patent/TN2014000127A1/en
Publication of TN2014000127A1 publication Critical patent/TN2014000127A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a pour objet des compositions pharmaceutiques effervescentes à désagrégation rapide destinés à l'administration par voie orale d'un glucorticoïde : le prednisolone métasulfobenzoate à titre de principe actif, sous forme d'ester libre ou de sel pharmaceutiquement actif. Les dites compositions se caractérisent par un temps de désagrégation inférieur à une minute, une teneur atténuée voire nulle en sodium et elles offrent un supplément de potassium permettant de compenser la fuite potassique pouvant être provoquée par le principe actif.The subject of the present invention is fast-disintegrating effervescent pharmaceutical compositions intended for the oral administration of a glucocorticoid: the prednisolone metasulfobenzoate as active principle, in the form of a free ester or of a pharmaceutically active salt. The said compositions are characterized by a disintegration time of less than one minute, an attenuated or even no sodium content and they offer a potassium supplement making it possible to compensate for the potassium leakage that may be caused by the active principle.

TNP2014000127A 2014-03-26 2014-03-26 EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME TN2014000127A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TNP2014000127A TN2014000127A1 (en) 2014-03-26 2014-03-26 EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TNP2014000127A TN2014000127A1 (en) 2014-03-26 2014-03-26 EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME

Publications (1)

Publication Number Publication Date
TN2014000127A1 true TN2014000127A1 (en) 2015-07-01

Family

ID=59742305

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2014000127A TN2014000127A1 (en) 2014-03-26 2014-03-26 EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME

Country Status (1)

Country Link
TN (1) TN2014000127A1 (en)

Similar Documents

Publication Publication Date Title
NZ742220A (en) Pharmaceutical compositions comprising meloxicam
CY1124052T1 (en) ORALLY DISPERSIBLE TABLET CONTAINING ESTETROL
MX2016010213A (en) Novel pharmaceutical formulations.
MA38399A1 (en) Formulation in tablet form, useful for treating acute heart failure and chronic heart failure
MA32692B1 (en) METHOD FOR RELEASING A PHARMACEUTICAL COMPOSITION FROM A PATIENT THAT NEEDS
MX2013014788A (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]am ino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids.
MA45598B1 (en) 24-hydroxy steroles substituted in position 11 for the treatment of diseases linked to the nmda receptor
MA35753B1 (en) Aryl-dihydropyridinones and piperidinones as mgat2 inhibitors
PH12017502416A1 (en) 17-hydroxyprogesterone ester-containing oral compositions and related methods
MX2020010300A (en) Mono-(acid) salts of 6-aminoisoquinolines and uses thereof.
MA38576A1 (en) Colchicine extended-release formulations and methods of using the same
RU2018136872A (en) COMPOSITIONS CONTAINING 15-OH EPA AND WAYS OF THEIR APPLICATION
EA201891267A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING EFFECTIVE URAT1 INHIBITOR
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
MX369571B (en) Composition for preventing or treating fatty liver diseases.
EA201691490A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BRINZOLAMIDE
MX2021002902A (en) Pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease, containing gpr119 ligand as active ingredient.
EA201990766A1 (en) INDOSOLIC COMPOUNDS FOR USE IN DAMAGE OF THE TENDON AND / OR Ligaments
EA201892842A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING SAFINAMID
JOP20180071B1 (en) Use of aminoalkylbenzothiazepine derivatives
TN2014000127A1 (en) EFFECTIVE, RAPID-REAGENT PHARMACEUTICAL COMPOSITION BASED ON PREDNISOLONE METASULFOBENZOATE AND METHOD FOR PRODUCING THE SAME
EA201991286A1 (en) A SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING TENOFOVIR AND EMTRITSITABIN
MX370184B (en) Pharmaceutical composition comprising fingolimod.
WO2018069805A3 (en) Method for preparation of liquid oral composition of l-thyroxin
PL419047A1 (en) Composition that contains furazidin and method for producing it